Stock Price Quote

GLAND PHARMA LTD.

NSE : GLANDBSE : 543245ISIN CODE : INE068V01023Industry : Pharmaceuticals & DrugsHouse : Private
BSE3723.4529.8 (+0.81 %)
PREV CLOSE ( ) 3693.65
OPEN PRICE ( ) 3749.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 29074
TODAY'S LOW / HIGH ( )3314.95 3750.00
52 WK LOW / HIGH ( )1701 4350
NSE3726.4032.45 (+0.88 %)
PREV CLOSE( ) 3693.95
OPEN PRICE ( ) 3680.00
BID PRICE (QTY) 3726.40 (188)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 997538
TODAY'S LOW / HIGH( ) 3312.15 3752.00
52 WK LOW / HIGH ( )1700 4350
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 20-03 1978
Management Info
Yiu Kwan Stanley Lau - Chairman Srinivas Sadu - Managing Director
Registered Office

Address Survey No. 143-148, 150 & 151,Near Gandimaisamma 'x' Roads, D. P. Pally,Dundigal Gandimaisamma Mandal, Medchal-malkajgiri District,
Hyderabad,
Telangana-500043

Phone 040 3051 0999

Email gland@glandpharma.com/investor@glandpharma.com

Website www.glandpharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

25Oct Gland Pharma informs about monitoring
Pursuant to Regulation 41(4) of SEBI (Issue of Capital and Disclosure Re..
23Oct Gland Pharma informs about press release
Gland Pharmahas informed that it enclosed copies of the newspaper advert..
11Oct Reliance Industries, Gland Pharma and
Reliance Industries’ (RIL) wholly owned subsidiary -- Reliance New Energ..
09Oct Gland Pharma gets USFDA’s tentative ap
Gland Pharma has received tentative approval from the United States Food..
08Oct Announcement under Regulation 30 (LOD
Product Tentative Approval : US FDA tentative approval for Sugammadex In..

Financials

in Millions
QTR Sep 21 ANNUAL 21
Net Profit3021.29970.05
Gross Profit 4007.04 13348.52
Operating Profit 4278.3814370.43
Net Sales 10804.6934628.76

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Torrent Pharma (BSE)
peergroup  3084.55 (3.91%)
M.Cap ( in Cr)52193.28
NGL Fine-Chem (BSE)
peergroup  2554.25 (4.38%)
M.Cap ( in Cr)1578.02
Venus Remedies (BSE)
peergroup  502.90 (14.73%)
M.Cap ( in Cr)672.23
Kwality Pharma (BSE)
peergroup  913.50 (5.00%)
M.Cap ( in Cr)947.87
Dr. Reddy's Lab (BSE)
peergroup  4675.45 (0.85%)
M.Cap ( in Cr)77798.93

Shareholding Pattern

PROMOTERS 58.02%
NON-INSTITUTION 19.21%
MUTUAL FUNDS/UTI 10.98%
FI/BANKS/INSURANCE 0.41%
GOVERNMENT 0%
FII 0%

About Gland Pharma Ltd.

Gland Pharma Ltd. was incorporated in the year 1978. Its today's share price is 3723.45. Its current market capitalisation stands at Rs 61176.98 Cr. In the latest quarter, company has reported Gross Sales of Rs. 34628.76 Cr and Total Income of Rs.35976.52 Cr. The company's management includes Allen Zhang, Udo Jahannes Vetter, Yifang Wu, Essaji Goolam Vahanvati, Satyanarayana Murthy Chavali, Naina Lal Kidwai, Xiaohui Guan, Dongming Li, Qiyu Chen, Srinivas Sadu, Yiu Kwan Stanley Lau, P Sampath Kumar.

It is listed on the BSE with a BSE Code of 543245 , NSE with an NSE Symbol of GLAND and ISIN of INE068V01023. It's Registered office is at Survey No. 143-148, 150 & 151,Near Gandimaisamma 'x' Roads, D. P. Pally,Dundigal Gandimaisamma Mandal, Medchal-malkajgiri DistrictHyderabad-500043, Telangana. Their Registrars are ACC Ltd. It's auditors are SR Batliboi & Associates LLP, SR Batliboi & Associates, LLP, Y Raghuram & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)